Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Data from cervical cancer vaccine programme 'encouraging'

  • 1 Comment

A vaccine targeting the human papillomavirus (HPV) has produced “encouraging” results.

The vaccination programme was introduced in Australia in 2007 and was available to all women aged from 12 to 26.

Results from the programme suggest the vaccine is effective at halting cervical cell abnormalities, although researchers said it was only suggestive evidence and that more work would be needed to confirm the results.

The researchers said that introducing the vaccine led to a reduced incidence of the high-grade abnormal cells that are precursors to cancer, adding that among girls under 18, incidences of high-grade cervical abnormalities (HGAs) fell by a significant 0.38%.

The team, led by Dr Julia Brotherton, from Victorian Cytology Service Registries in Melbourne, wrote in The Lancet medical journal: “This is the first report of a decrease in incidence of high-grade cervical abnormalities within three years after implementation of a population-wide HPV vaccination programme.”

  • 1 Comment

Readers' comments (1)

  • If you're living with herpes or other STDs, this may help. HerpesGroups is a safe and unique community for singles with herpes to connect with others in the same situation.
    You can find support groups to talk about herpes symptoms, treatments, meet new friends and even find love with someone that understands what you go through.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.